Evotec and Odyssey Therapeutics Start AI Drug Discovery Collaboration
Aug 06, 2026
Biotech
DeepCyte Launches DeeTox Atlas for AI Toxicology
August 19, 2026
DeepCyte launched DeeTox Atlas, a single cell metabolomic reference atlas for drug toxicity mechanisms, with pharma pilots starting in the coming months.
DeepCyte launched DeeTox Atlas™, which it describes as a single cell metabolomic reference atlas of drug toxicity mechanisms, the company announced in a press release. Pilot programs with global pharmaceutical companies are set to begin in the coming months.
The atlas is built from two independent single cell metabolomics perturbation studies. It covers about 100 toxicant compounds, 300,000 cells, about 500 metabolites per cell, and more than 3,000 single cell measurements per compound across six biological replicates.
Each compound is mapped to a four level hierarchy of toxicity mechanisms tied to Adverse Outcome Pathways. DeepCyte trains a foundation model on the atlas to predict toxicity mechanisms for compounds it has not measured.
The company also named Mona Lakkis as Senior Vice President of Partnerships. Lakkis previously served as Senior Vice President and General Manager at Owkin and will lead enterprise commercialization as DeepCyte advances pilots with three of the top 20 pharmaceutical companies.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
08/19
Oracle Health Adds Coding and Dictation to Clinical AI Agent
08/19
Empatica Gets FDA Clearance for Parkinson's Monitoring Platform
08/19
Luma Health and PCC Add AI Communications to Pediatric EHR
08/19
Ours Privacy Raises $15M for Healthcare Marketing Data Platform
08/19
SandboxAQ Makes AQPotency Available for Drug Discovery
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
ModelOp
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more